The frequency of complications associated with the use of multiple-dose activated charcoal

Annals of Emergency Medicine

Volumn 41, Issue 3, 2003, Pages 370-377

  Dorrington, Catherine L ^a   Johnson, David W ^a,b   Brant, Rollin ^a   Berlin, Randall ^c   Daya, Mohamud ^c   Purssell, Roy ^c   Mullins, Michael ^c   Vohra, Sunita ^c   McOiarmid, Adam ^c   Dorrington, Cathy ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; AMITRIPTYLINE; CARBAMAZEPINE; CHLORPROMAZINE; CODEINE; DIPHENHYDRAMINE; FLUOXETINE; HALOPERIDOL; LOXAPINE; METHOCARBAMOL; PARACETAMOL; PHENYTOIN; THEOPHYLLINE; ZOPICLONE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORNEA INJURY; DEMOGRAPHY; DOCUMENTATION; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERMAGNESEMIA; HYPERNATREMIA; INTESTINE OBSTRUCTION; INTOXICATION; LUNG ASPIRATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NORTH AMERICA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; STOMACH MOTILITY;

EID: 0037370375     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.86     Document Type: Article

References (31)

1. Bradberry SM, Vale JA. Multiple-dose activated charcoal: a review of relevant clinical studies. Clin Toxicol. 1995;33:407-416.
2. Chyka PA. Multiple-dose activated charcoal and enhancement of systemic drug clearance: summary of studies in animals and human volunteers. Clin Toxicol. 1995;33:399-405.
3. McLuckie A, Forbes AM, Ilett KF. Role of repeated doses of oral activated charcoal in the treatment of acute intoxications. Anaesth Intensive Care. 1990;18:375-384.
4. Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses. Med Toxicol. 1988;3:33-58.
5. Pond SM. Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol. 1986;1:3-11.
6. Pond SM, Olson KR, Osterloh JD, et al. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA. 1984;251:3104-3108.
7. Anderson IM, Ware C. Drug points: syrup of ipecacuanha [letter]. BMJ. 1987;294:578.
8. Atkinson SW, Young Y, Trotter GA. Treatment with activated charcoal complicated by gastrointestinal obstruction requiring surgery. BMJ. 1992;305:563.
9. Benson B, VanAntwerp M, Hergott T. A fatality resulting from multiple dose activated charcoal therapy [abstract]. Vet Hum Toxicol. 1989;31:335.
10. Flores F, Battle WS. Intestinal obstruction secondary to activated charcoal. Contemp Surg. 1987;30:57-59.
11. George DL, McLeod R, Weinstein RA. Contaminated commercial charcoal as a source of fungi in the respiratory tract. Infect Control Hosp Epidemiol. 1991;12:732-734.
12. Givens T, Holloway M, Watson S. Pulmonary aspiration of activated charcoal: a complication of its misuse in overdose management. Pediatr Emerg Care. 1992;8:137-140.
13. Gomez HF, Brent JA, Munoz DC, et al. Charcoal stercolith with intestinal perforation in a patient treated for amitriptyline ingestion. J Emerg Med. 1994;12:57-60.
14. Goulbourne KB, Cisek JE. Small-bowel obstruction secondary to activated charcoal and adhesions. Ann Emerg Med. 1994;24:108-110.
15. Harris CR, Filandrinos D. Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med. 1993;22:1470-1473.
16. Harsch HH. Aspiration of activated charcoal. N Engl J Med. 1986;314:318.
17. Longdon P, Henderson A. Intestinal pseudo-obstruction following the use of enteral charcoal and sorbitol and mechanical ventilation with papaveretum sedation for theophylline poisoning. Drug Safety. 1992;7:74-77.
18. Mauro LS, Nawarskas JJ, Mauro VF. Misadventures with activated charcoal and recommendations for safe use. Ann Pharmacother. 1994;28:915-924.
19. Menzies DG, Busuttil A, Prescott LF. Fatal pulmonary aspiration of oral activated charcoal. BMJ. 1988;297:459-460.
20. Merriman T, Stokes K. Small bowel obstruction secondary to administration of activated charcoal. Aust N Z J Surg. 1995;65:288-289.
21. Rau NR, Nagaraj MV, Prakash PS, et al. Fatal pulmonary aspiration of oral activated charcoal. BMJ. 1988;297:918-919.
22. Ray MJ, Padin DR, Condie JD, et al. Charcoal Bezoar. Small-bowel obstruction secondary to amitryptyline overdose therapy. Dig Dis Sci. 1988;33:106-107.
23. Watson WA, Cremer KF, Chapman JA. Gastrointestinal obstruction associated with multiple-dose activated charcoal. J Emerg Med. 1988;4:401-407.
24. Watson WA. Misadventures with activated charcoal. Ann Pharmacother. 1995;29:84-85.
25. Elliott CG, Colby TV, Kelly TM, et al. Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest. 1989;96:672-674.
26. Damman KZ, Wiley SH, Tominack RL. Aspiration pneumonia following activated charcoal - a case report. Vet Hum Toxicol. 1988;30:353.
27. Pollack MM, Dunbar BS, Holbrook PR, et al. Aspiration of activated charcoal and gastric contents. Ann Emerg Med. 1981;10:528-529.
28. Tenenbein M. Multiple doses of activated charcoal: time for reappraisal? Ann Emerg Med. 1991;20:529-531.
29. Vale JA, Krenzelok EP, Barceloux DG. American Academy of Clinical Toxicology and European Association of Poison Centres and Clinical Toxicologists position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol. 1999;37:731-751.
30. Moll J, Kerns WI, Tomaszewski C, et al. Incidence of aspiration pneumonia in intubated patients receiving activated charcoal. J Emerg Med. 1999;17:279-283.
31. McKinney PE, Phillips S, Gomez HF, et al. Corneal abrasions secondary to activated charcoal. Am J Emerg Med. 1993;11:562.